http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102094338-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate | 2018-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102094338-B1 |
| titleOfInvention | the composition comprising the extract of Veronicastrum sibiricum L. Pennell as an active ingredient for preventing or treating inflammation, allergy and asthma and the use there of |
| abstract | The present invention relates to a composition for preventing or treating inflammation, allergies and asthma, which contains an extract of cold vinegar (Veronicastrum sibiricum L. Pennell; Veronicastrum: cold vinegar) as an active ingredient. Cold vinegar extract according to the present invention is a leukotriene (leukotriene) generation inhibitory ability evaluation test (Experimental Example 1); Experiment on the effect on total cell count in total bronchoalveolar lavage (BAL) using Balb / c male mouse (Experimental Example 2); Experimental effect on the number of neutrophil cells compared to the total number of cells in total bronchoalveolar lavage (BAL) (Experimental Example 3); Experiment on the effect on the number of Neutrophil + / Gr-1 + absolute cells in bronchoalveolar lavage fluid (Experimental Example 4); Experiment on the effect on the number of CD11b + / Gr-1 + absolute cells in lung cells (Experimental Example 5); Experiment on the effect on the number of CD4 + / CD3 + absolute cells in lung cells (Experimental Example 6); Effect of macrophage + / CD11b + absolute cells in lung cells (Experimental Example 7); Experiment on the effect of bronchoalveolar lavage fluid (BAL fluid) on inflammatory factor expression level (Experimental Example 8); Through the animal experiments such as the effect on lung tissue changes (Experimental Example 9), it was confirmed that it exhibits excellent anti-inflammatory, anti-allergic and asthma-inhibiting activity, pharmaceutical composition for prevention or treatment of inflammation, allergy and asthma disease, health functional food Or it is useful as a dietary supplement. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102378498-B1 |
| priorityDate | 2018-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.